InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Mandelia Ashish, Vice-Président, Contrôleur. Officer active across 1 company, notably Mersana Therapeutics, Inc.. In total, 9 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €11k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 15 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Mandelia Ashish is Vice-President, Controller at Mersana Therapeutics, Inc. The 9 filings on record concern Mersana Therapeutics, Inc., and the sampled recent filings from 2021-07-02 to 2026-01-06 show sales of EUR 10815 and no purchases, with Levée d'options as the most frequent transaction nature.